Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Urology
Published in: BMC Urology 1/2018

Open Access 01-12-2018 | Research article

What predicts emotional response in men awaiting prostate biopsy?

Authors: AnnMarie Groarke, Ruth Curtis, Deirdre M. J. Walsh, Francis J. Sullivan

Published in: BMC Urology | Issue 1/2018

Login to get access

Abstract

Background

Incidence of prostate cancer is increasing as opportunistic screening becomes widespread and life expectancy rises. Despite screening availability, research reveals conflicting results on medical outcomes, for example, disease specific mortality. However the gold standard in early diagnosis of potentially curable organ confined prostate cancer is transrectal ultrasound-guided systematic prostate biopsy (TRUS-BX). While focus has been given to medical sequalae there is a paucity of research on the psychological impact of biopsy. Awaiting biopsy may be inherently stressful but no studies to date, have assessed men’s perception of stress and its impact on emotional response. This study, therefore, examines the role of stress and also personal resources namely, self-efficacy and sense of coherence in emotional adjustment in men awaiting a prostate biopsy.

Methods

Men attending a Rapid Access Prostate Cancer Clinic for a transrectal prostate biopsy (N = 114) participated in the study. They completed self report questionnaires on perceived stress (PSS), generalised self-efficacy (GSES), and sense of coherence (SOC). Adjustment was measured by the Profile of Mood States (POMS-B) which assesses tension, depression, anger, fatigue, confusion and vigour.

Results

Hierarchical regression analyses demonstrated that the set of predictors accounted for 17%–34% of variance across six mood states and predicted 46% of total mood disturbance. Perceived stress explained variance on all domains (11%–26%) with high stress linked to poor functioning.

Conclusion

Perceived stress was the strongest and most consistent predictor of emotional adjustment. This is an important finding as stress appraisal has not been examined previously in this context and suggests that stress management is an important target to enhance emotional wellbeing of men attending for a prostate biopsy.
Literature
1.
Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin. 2001;51:15–36.CrossRefPubMed
2.
Raja J, Ramachandran N, Munneke G, Patel U. Current status of transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer. Clin Radiol. 2006;61:142–53.CrossRefPubMed
3.
4.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.CrossRefPubMed
5.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360:1320–8.CrossRefPubMed
6.
Hugosson J, Carlsson S, Aus G, Bergdahl S, Khatami A, Lodding P, Pihl C-G, Stranne J, Holmberg E, Lilja H. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial. The. Lancet Oncol. 2010;11:725–32.CrossRefPubMedPubMedCentral
7.
Andriole GL, Crawford ED, Grubb IIIRL, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ. Mortality results from a randomized prostate-cancer screening trial. New Engl J Med. 2009;360:1310–9.CrossRefPubMedPubMedCentral
8.
Bellardita L, Valdagni R, Van Den Bergh R, Randsdorp H, Repetto C, Venderbos LD, Lane JA, Korfage IJ. How does active surveillance for prostate cancer affect quality of life? A systematic review. Eur Urol. 2015;67:637–45.CrossRefPubMed
9.
Drummond FJ, O’Leary E, Gavin A, Kinnear H, Sharp L. Mode of prostate cancer detection is associated with the psychological wellbeing of survivors: results from the PiCTure study. Support Care Cancer. 2016;24:2297–307.CrossRefPubMed
10.
Chapple A, Ziebland S, Brewster S, McPherson A. Patients’ perceptions of transrectal prostate biopsy: a qualitative study. Eur J Cancer Care. 2007;16:215–21.CrossRef
11.
Glaser AP, Novakovic K, Helfand BT. The impact of prostate biopsy on urinary symptoms, erectile function, and anxiety. Curr Urol Rep. 2012;13:447–54.CrossRefPubMed
12.
Ilic D, O’Connor D, Green S, Wilt TJ. Screening for prostate cancer: an updated Cochrane systematic review. BJU Int. 2011;107:882–91.CrossRefPubMed
13.
Loeb S, van den Heuvel S, Zhu X, Bangma CH, Schröder FH, Roobol MJ. Infectious complications and hospital admissions after prostate biopsy in a European randomized trial. Eur Urol. 2012;61(6):1110–4.CrossRefPubMed
14.
Medd JC, Stockler MR, Collins R, Lalak A. Measuring men's opinions of prostate needle biopsy. ANZ J Surg. 2005;75:662–4.CrossRefPubMed
15.
Appleton L, Wyatt D, Perkins E, Parker C, Crane J, Jones A, Moorhead L, Brown V, Wall C, Pagett M. The impact of prostate cancer on men's everyday life. Eur J Cancer Care. 2015;24:71–84.CrossRef
16.
Zisman A, Leibovici D, Kleinmann J, Siegel YI, Lindner A. The impact of prostate biopsy on patient well-being: a prospective study of pain, anxiety and erectile dysfunction. Journal Urol. 2001;165:445–54.CrossRef
17.
Awsare N, Green J, Aldwinckle B, Hanbury D, Boustead G, McNicholas T. The measurement of psychological distress in men being investigated for the presence of prostate cancer. Prostate Cancer and Prostatic Dis. 2008;11:384–9.CrossRef
18.
Saraçoglu T, Ünsal A, Taskin F, Sevinçok L, Karaman CZ. The impact of pre-procedural waiting period and anxiety level on pain perception in patients undergoing transrectal ultrasound-guided prostate biopsy. Diagn Interv Radiol. 2012;18:195.PubMed
19.
Fowler FJ, Barry MJ, Walker-Corkery B, Caubet JF, Bates DW, Lee JM, Hauser A, McNaughton-Collins M. The impact of a suspicious prostate biopsy on Patients' psychological, socio-behavioral, and medical care outcomes. J Gen Intern Med. 2006;21:715–21.CrossRefPubMedPubMedCentral
20.
Macefield R, Metcalfe C, Lane J, Donovan J, Avery K, Blazeby J. Down L, Neal D, Hamdy F, Vedhara K: impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result. Br J Cancer. 2010;102:1335–40.CrossRefPubMedPubMedCentral
21.
Wade J, Rosario DJ, Macefield RC, Avery KN, Salter CE, Goodwin ML, Blazeby JM, Lane JA, Metcalfe C, Neal DE. Psychological impact of prostate biopsy: physical symptoms, anxiety, and depression. J Clin Oncol. 2013;31(33):4235–4241.
22.
Cohen S. Aftereffects of stress on human performance and social behavior: a review of research and theory. Psychol Bull. 1980;88:82.CrossRefPubMed
23.
Lazarus RS, Folkman S: Stress, appraisal, and coping. New York: Springer publishing company; 1984.
24.
25.
Gustafsson O, Theorell T, Norming U, Perski A, Öhström M, Nyman C. Psychological reactions in men screened for prostate cancer. Brit J Urol. 1995;75:631–6.CrossRefPubMed
26.
27.
Steginga SK, Occhipinti S. Dispositional optimism as a predictor of men's decision-related distress after localized prostate cancer. Health Psychol. 2006;25(2):135.CrossRefPubMed
28.
Bandura A. Self-efficacy: the exercise of control. New York: Freeman; 1997.
29.
Antonovsky A: Unraveling the mystery of health: How people manage stress and stay well. San Francisco: Jossey-Bass; 1987.
30.
Taylor SE. Adjustment to threatening events: a theory of cognitive adaptation. Am Psychol. 1983;38:1161.CrossRef
31.
Haugland T, Wahl AK, Hofoss D, DeVon HA. Association between general self-efficacy, social support, cancer-related stress and physical health-related quality of life: a path model study in patients with neuroendocrine tumors. Health Quality Life Outcomes. 2016;14:1.CrossRef
32.
Sarenmalm EK, Browall M, Persson LO, Fall-Dickson J, Gaston-Johansson F. Relationship of sense of coherence to stressful events, coping strategies, health status, and quality of life in women with breast cancer. Psychooncology. 2013;22:20–7.CrossRef
33.
Lev EL, Eller LS, Gejerman G, Kolassa J, Colella J, Pezzino J, Lane P, Munver R, Esposito M, Sheuch J. Quality of life of men treated for localized prostate cancer: outcomes at 6 and 12 months. Support Care Cancer. 2009;17:509–17.CrossRefPubMed
34.
Bandura A. Exercise of personal agency through the self-efficacy mechanism. In: Schwarzer R, editor. Self-efficacy: thought control of action. Washington DC: Hemisphere Publishing Corp; 1992. p. 3–38.
35.
Jerusalem M, Schwarzer R, Schwarzer R. Self-efficacy as a resource factor in stress appraisal processes. In: Self-efficacy: Thought control of action; 1992. p. 195–213.
36.
Orom H, Nelson CJ, Underwood W, Homish DL, Kapoor DA. Factors associated with emotional distress in newly diagnosed prostate cancer patients. Psychooncology. 2015;24:1416–22.CrossRefPubMedPubMedCentral
37.
Gustavsson-Lilius M, Julkunen J, Keskivaara P, Hietanen P. Sense of coherence and distress in cancer patients and their partners. Psychooncology. 2007;16:1100–10.CrossRefPubMed
38.
Hyphantis T, Papadimitriou I, Petrakis D, Fountzilas G, Repana D, Assimakopoulos K, Carvalho AF, Pavlidis N. Psychiatric manifestations, personality traits and health-related quality of life in cancer of unknown primary site. Psychooncology. 2013;22:2009–15.CrossRefPubMed
39.
Winger JG, Adams RN, Mosher CE. Relations of meaning in life and sense of coherence to distress in cancer patients: a meta-analysis. Psychooncology. 2016;25:2–10.CrossRefPubMed
40.
Gilbar O. Do attitude toward cancer, sense of coherence and family high risk predict more psychological distress in women referred for a breast cancer examination? Women & health. 2003;38(2):35–46.CrossRef
41.
Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24: 385–96.
42.
Antonovsky A. The structure and properties of the sense of coherence scale. Soc Sci Med. 1993;36:725–33.CrossRefPubMed
43.
McNair D, Lorr M, Droppelman L. EDITS manual for the profile of mood states: manual. San Diego, Calif: Educational and Testing Service; 1992.
44.
McNair DM, Heuchert P: Profile of mood states: POMS: technical update: multi-health systems; 2007.
45.
Cohen J. Statistical power analysis for the behavioural sciences. Lawrence Earlbaum Associates: Hillside. NJ; 1988.
46.
Tabachnick BG, Fidell LS. 6th ed. using multivariate statistics. Essex: Pearson Education limited; 2014.
47.
Allison P. Missing data. Thousand Oaks, CA: Sage; 2001.
48.
Graham JW. Missing data analysis: making it work in the real world. Ann. Rev Psychol. 2009;60:549–76.CrossRef
49.
Scheffer J. Dealing with missing data. Research Letters in the Information and Mathematical Sciences. 2002;31:53–160.
50.
Tarhan H, Cakmak O, Unal E, Akarken I, Un S, Ekin RG, et al. The effect of video-based education on patient anxiety in men undergoing transrectal prostate biopsy. Can Urol Assoc J. 2014;8(11–12):894–900.CrossRef
51.
Parahoo K, McDonough S, McCaughan E, Noyes J, Semple C, Halstead EJ, Neuberger MM, Dahm P. Psychosocial interventions for men with prostate cancer: a Cochrane systematic review. BJU Intern. 2015;116:174–83.CrossRef
52.
Newby TA, Graff JN, Ganzini LK, McDonagh MS. Interventions that may reduce depressive symptoms among prostate cancer patients: a systematic review and meta-analysis. Psychooncology. 2015;24:1686–93.CrossRefPubMed
53.
Leventhal H, Nerenz DR, Purse J: Illness representations and coping with health threats; 1984.
54.
55.
Cowens-Alvarado R, Sharpe K, Pratt-Chapman M, Willis A, Gansler T, Ganz PA, Edge SB, McCabe MS, Stein K. Advancing survivorship care through the National Cancer Survivorship Resource Center. CA: Canc J Clin. 2013;63:147–50.
56.
Holland JC, Bultz BD. The NCCN guideline for distress management: a case for making distress the sixth vital sign. J National Compr Canc Netw. 2007;5:3–7.CrossRef
Metadata
Title
What predicts emotional response in men awaiting prostate biopsy?
Authors
AnnMarie Groarke
Ruth Curtis
Deirdre M. J. Walsh
Francis J. Sullivan
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Urology / Issue 1/2018
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-018-0340-9

Other articles of this Issue 1/2018

BMC Urology 1/2018 Go to the issue

Research article

Longitudinal recovery patterns of penile length and the underexplored benefit of long-term phosphodiesterase-5 inhibitor use after radical prostatectomy

Research article

Supportive interventions to improve physiological and psychological health outcomes among patients undergoing cystectomy: a systematic review

Research article

The location of the bladder neck in postoperative cystography predicts continence convalescence after radical prostatectomy

Correction

Correction to: Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials

Research article

Efficacy and safety of PDE5-Is and α-1 blockers for treating lower ureteric stones or LUTS: a meta-analysis of RCTs

Research article

Effect of sample time on urinary lithogenic risk indexes in healthy and stone-forming adults and children